The high overlap between differentially regulated genes co-bound by ZNF217 and ERα and the poor prognosis of patients with breast tumors that overexpress ZNF217 suggested that ZNF217 may have a regulatory role in expression changes that occur in tamoxifen-resistant breast tumors. The gene discussed is ESR1; the disease is breast neoplasm.